A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer von Besse, B., Heist, R.S., Papadmitrakopoulou, V.A., Camidge, D.R., Beck, J.T., Schmid, P., Mulatero, C., Miller, N., Dimitrijevic, S., Urva, S., Pylvaenaeinen, I., Petrovic, K., Johnson, B.E.

Volltext